Heat stable nutritional beverage and method of preparing it

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Campina Nederland Holding B.V. patent solves the following problem:

A heat strong, whey-containing nutritional drink known from WO 2006/119064, which describes a novel aseptic drink and pudding that contains at least 2% whey, and a process for making it.

Our analysis of this patent is as follows:

Campina Nederland Holding B.V.’s patent US 8263164 B2 deals with Heat stable nutritional beverage and method of preparing it.
A heat strong nutritional drink with a pH of 6.6-8.2 containing 5-12% w / w whey protein obtained through the use of 4-16% w / w at least one sugar chosen from non-oligo- and polysaccharides, wherein at least one monosaccharide other than glucose.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Consumable holder with converter

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Whirlpool Corporation patent solves the following problem:

The invention relates to devices that hold consumables used or operated by a communication tool.

Our analysis of this patent is as follows:

Whirlpool Corporation’s patent US 8264318 B2 deals with Consumable holder with converter.
A consumable holder provided for use in an appliance configured to perform an operation cycle related to a consumable consumable holder. The consumable holders are able to obtain information relating to himself or consumable, and further includes a converter configured to transform the information into a cycle structure. Therefore, the consumable holder communicate with one engine cycle to create or change a cycle structure for using the appliance to perform an operation cycle related consumable.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Human -adrenergic receptor kinase polypeptide and methods

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Incyte Corporation patent solves the following problem:

Change protein phosphorylation is ubiquitous methods used to control many of intracellular events in eukaryotic cells. It is estimated that more than ten percent of the active protein in a typical mammal cell are phosphorylated. Kinases to facilitate the transfer of high-energy phosphate group from adenosine triphosphate (ATP) to the target protein hydroxyamino acid residues serine, threonine, or tyrosine. Phosphatases, in contrast, take the phosphate groups. Extracellular signal including hormone; neurotransmitter, growth and inequality factors may activate kinases, which takes place as the cell surface of cells or as activator in the final effector proteins, as well as other places along the way signal transduction. Cascade of kinases occur, as well as sensitive kinases second messenger molecules. This system allows for equipment to amplify the weak signal (lower abundance of growth factor molecules, for example), as well as the synthesis of many weak signal into an all-or-nothing answer. Phosphatases, then, is necessary to determine the extent of phosphorylation in cells and, with kinases, controlling key cellular processes such as metabolic enzyme activity, proliferation, cell growth and inequality, cell adhesion, and cell cycle progression.

Our analysis of this patent is as follows:

Incyte Corporation’s patent US 8263378 B2 deals with Human -adrenergic receptor kinase polypeptide and methods.
Various embodiments of the invention provide human kinases and phosphatases (KPP) polypeptides and polynucleotides which identify and encode KPP. Embodiments of the invention also giving expression vector, host cells, antibodies, agonists and antagonists. Some embodiments provide methods for diagnosing, treating, or preventing diseases associated with aberrant expression of KPP.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.